For more than 30 years, Emerging Therapy Solutions® (ETS) has helped payers manage medicine’s most complex, high-cost treatments beginning with solid organ and stem cell transplants.
Today, we’re applying our transplant experience to cell & gene therapy—and building the infrastructure needed as advanced therapies move from rare events to treating more common conditions and to support next-generation therapies as they evolve.
ETS supports employers, health plans, secondary payers, brokers and patients with the expertise, provider relationships, analytics and clinical infrastructure needed to manage advanced therapies from risk identification through treatment and outcomes at the best possible price.
To make the most complex care in healthcare easier to access, navigate and afford.
The ETS360 Platform brings predictive intelligence, specialized provider navigation, clinical management, patient support and financial strategy together in one integrated framework for transplant, cell & gene therapy and the next generation of advanced and personalized treatments.
Our story continues with the same purpose and values that shaped our beginning: helping clients manage complex therapies and supporting the people who need them.
See Our Solutions.
Transparency. Patient-Centeredness. Collaboration. Visionary. Responsiveness.
From transplant to cell and gene therapy, our experience informs every step forward. Through ETS360, we bring proven capabilities together in one integrated platform designed to support today’s complex treatments and evolve with tomorrow’s therapies.
2026 Minneapolis/St. Paul Business Journal Fast 50 Honoree
Version 8.2- Comprehensive Program
Effective Date: February 1, 2026
Expiration Date: February 1, 2029
Certification Date: June 1, 2026
Expiration Date: May 1, 2027
Connect with ETS to explore how our experience can help you navigate complex therapies today and plan for tomorrow.
Copyright © 2026. Emerging Therapy Solutions. All Rights Reserved.
